Fosifloxuridine nafalbenamide
N/A
Report date: 2026/03/17 20:00:15
NME
Base Information
Drug NameFosifloxuridine nafalbenamide
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[16]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[6]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCardiff University
China Registration ClassN/A
Develop Information
Active CompaniesNucana Plc
Inactive CompaniesUniversity Of Oxford
Active Indications
Inactive Indications +[15]
Other Information
ATC CodeN/A
Related LinksN/A